Imugene (ASX:IMU) appointed Clinuvel Pharmaceuticals' (ASX:CUV) former Chief Financial Officer Darren Keamy as CFO, effective immediately, according to a Tuesday filing with the Australian bourse.
Keamy will succeed current CFO Mike Tonroe, the filing said.
Shares of the pharmaceutical company fell 3% in recent trade,
Price (AUD): $0.04, Change: $-0.00100, Percent Change: -2.78%
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。